Yelena Y Janjigian

Yelena Y Janjigian

UNVERIFIED PROFILE

Are you Yelena Y Janjigian?   Register this Author

Register author
Yelena Y Janjigian

Yelena Y Janjigian

Publications by authors named "Yelena Y Janjigian"

Are you Yelena Y Janjigian?   Register this Author

71Publications

2851Reads

44Profile Views

Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer": Are we There Yet?

Ann Surg 2019 Aug;270(2):e39-e40

Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY Department of Surgery, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000003100DOI Listing
August 2019

Application of positron emission tomography imaging to personalize esophagogastric cancer care.

Cancer 2019 Apr 22;125(8):1214-1217. Epub 2019 Jan 22.

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31940DOI Listing
April 2019

Current and Future Aspects of Immunotherapy for Esophageal and Gastric Malignancies.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:237-247. Epub 2019 May 17.

6 Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_236699DOI Listing
January 2019

Talking to patients about biosimilars.

Future Oncol 2018 Oct 1;14(23):2403-2414. Epub 2018 Jun 1.

Pfizer Ltd, Sandwich, Kent, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0044DOI Listing
October 2018

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.

J Clin Oncol 2018 10 15;36(28):2836-2844. Epub 2018 Aug 15.

Yelena Y. Janjigian, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Johanna Bendell, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN; Emiliano Calvo, START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain; Joseph W. Kim, Yale Cancer Center, New Haven, CT; Paolo A. Ascierto, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples; Filippo de Braud, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy; Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX; Patrick A. Ott, Dana-Farber Cancer Institute, Boston, MA; Katriina Peltola, Docrates Cancer Center, Helsinki, Finland; Dirk Jaeger, University Hospital Heidelberg, Heidelberg, Germany; Jeffry Evans, University of Glasgow, Glasgow; Ian Chau, Royal Marsden Hospital, London and Surrey, United Kingdom; Christopher T. Harbison, Cecile Dorange, Marina Tschaika, Bristol-Myers Squibb, Princeton, NJ; and Dung T. Le, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.6212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161834PMC
October 2018

Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer.

Ann Thorac Surg 2018 09 5;106(3):864-871. Epub 2018 May 5.

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2018.04.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117834PMC
September 2018

Checkpoint blockade in esophagogastric cancer.

J Surg Oncol 2018 Jul 7;118(1):77-85. Epub 2018 Jun 7.

Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25116DOI Listing
July 2018

Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.

Ann Surg 2017 12;266(6):1006-1012

*Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY †Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY ‡Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY §Department of Gastroenterology, Memorial Sloan Kettering Cancer Center, New York, NY ¶Department of Medicine, Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000002030DOI Listing
December 2017

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:
Ahmet Zehir Ryma Benayed Ronak H Shah Aijazuddin Syed Sumit Middha Hyunjae R Kim Preethi Srinivasan Jianjiong Gao Debyani Chakravarty Sean M Devlin Matthew D Hellmann David A Barron Alison M Schram Meera Hameed Snjezana Dogan Dara S Ross Jaclyn F Hechtman Deborah F DeLair JinJuan Yao Diana L Mandelker Donavan T Cheng Raghu Chandramohan Abhinita S Mohanty Ryan N Ptashkin Gowtham Jayakumaran Meera Prasad Mustafa H Syed Anoop Balakrishnan Rema Zhen Y Liu Khedoudja Nafa Laetitia Borsu Justyna Sadowska Jacklyn Casanova Ruben Bacares Iwona J Kiecka Anna Razumova Julie B Son Lisa Stewart Tessara Baldi Kerry A Mullaney Hikmat Al-Ahmadie Efsevia Vakiani Adam A Abeshouse Alexander V Penson Philip Jonsson Niedzica Camacho Matthew T Chang Helen H Won Benjamin E Gross Ritika Kundra Zachary J Heins Hsiao-Wei Chen Sarah Phillips Hongxin Zhang Jiaojiao Wang Angelica Ochoa Jonathan Wills Michael Eubank Stacy B Thomas Stuart M Gardos Dalicia N Reales Jesse Galle Robert Durany Roy Cambria Wassim Abida Andrea Cercek Darren R Feldman Mrinal M Gounder A Ari Hakimi James J Harding Gopa Iyer Yelena Y Janjigian Emmet J Jordan Ciara M Kelly Maeve A Lowery Luc G T Morris Antonio M Omuro Nitya Raj Pedram Razavi Alexander N Shoushtari Neerav Shukla Tara E Soumerai Anna M Varghese Rona Yaeger Jonathan Coleman Bernard Bochner Gregory J Riely Leonard B Saltz Howard I Scher Paul J Sabbatini Mark E Robson David S Klimstra Barry S Taylor Jose Baselga Nikolaus Schultz David M Hyman Maria E Arcila David B Solit Marc Ladanyi Michael F Berger

Nat Med 2017 08;23(8):1004

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0817-1004cDOI Listing
August 2017

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:
Ahmet Zehir Ryma Benayed Ronak H Shah Aijazuddin Syed Sumit Middha Hyunjae R Kim Preethi Srinivasan Jianjiong Gao Debyani Chakravarty Sean M Devlin Matthew D Hellmann David A Barron Alison M Schram Meera Hameed Snjezana Dogan Dara S Ross Jaclyn F Hechtman Deborah F DeLair JinJuan Yao Diana L Mandelker Donavan T Cheng Raghu Chandramohan Abhinita S Mohanty Ryan N Ptashkin Gowtham Jayakumaran Meera Prasad Mustafa H Syed Anoop Balakrishnan Rema Zhen Y Liu Khedoudja Nafa Laetitia Borsu Justyna Sadowska Jacklyn Casanova Ruben Bacares Iwona J Kiecka Anna Razumova Julie B Son Lisa Stewart Tessara Baldi Kerry A Mullaney Hikmat Al-Ahmadie Efsevia Vakiani Adam A Abeshouse Alexander V Penson Philip Jonsson Niedzica Camacho Matthew T Chang Helen H Won Benjamin E Gross Ritika Kundra Zachary J Heins Hsiao-Wei Chen Sarah Phillips Hongxin Zhang Jiaojiao Wang Angelica Ochoa Jonathan Wills Michael Eubank Stacy B Thomas Stuart M Gardos Dalicia N Reales Jesse Galle Robert Durany Roy Cambria Wassim Abida Andrea Cercek Darren R Feldman Mrinal M Gounder A Ari Hakimi James J Harding Gopa Iyer Yelena Y Janjigian Emmet J Jordan Ciara M Kelly Maeve A Lowery Luc G T Morris Antonio M Omuro Nitya Raj Pedram Razavi Alexander N Shoushtari Neerav Shukla Tara E Soumerai Anna M Varghese Rona Yaeger Jonathan Coleman Bernard Bochner Gregory J Riely Leonard B Saltz Howard I Scher Paul J Sabbatini Mark E Robson David S Klimstra Barry S Taylor Jose Baselga Nikolaus Schultz David M Hyman Maria E Arcila David B Solit Marc Ladanyi Michael F Berger

Nat Med 2017 Jun 8;23(6):703-713. Epub 2017 May 8.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nm.4333
Publisher Site
http://dx.doi.org/10.1038/nm.4333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461196PMC
June 2017

Gastric adenocarcinoma.

Nat Rev Dis Primers 2017 Jun 1;3:17036. Epub 2017 Jun 1.

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2017.36DOI Listing
June 2017

Current Progress in Human Epidermal Growth Factor Receptor 2 Targeted Therapies in Esophagogastric Cancer.

Surg Oncol Clin N Am 2017 04 10;26(2):313-324. Epub 2017 Feb 10.

Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Room 1033, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.10.005DOI Listing
April 2017

It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma.

J Clin Oncol 2017 02 28;35(4):475-477. Epub 2016 Oct 28.

Elena Elimova, University of Texas MD Anderson Cancer Center, Houston, TX; Yelena Y. Janjigian, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Mary Mulcahy, Feinberg School of Medicine, Lurie Comprehensive Cancer Center, Chicago, IL; Daniel V. Catenacci, University of Chicago, Chicago, IL; Mariela A. Blum, University of Texas MD Anderson Cancer Center, Houston, TX; Khaldoun Almhanna, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; J. Randolph Hecht, David Geffen School of Medicine, University of California Los Angeles, Santa Monica, CA; and Jaffer A. Ajani, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.7276DOI Listing
February 2017

Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma.

J Gastrointest Oncol 2016 Dec;7(6):828-837

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2016.08.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177593PMC
December 2016

The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond.

J Gastrointest Oncol 2016 Oct;7(5):750-762

Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA;; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2016.06.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056254PMC
October 2016

Clinical impact of tumour biology in the management of gastroesophageal cancer.

Nat Rev Clin Oncol 2016 06 1;13(6):348-60. Epub 2016 Mar 1.

Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, 1275 York Avenue, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521012PMC
June 2016

Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.

J Surg Oncol 2016 Jun 4;113(7):745-9. Epub 2016 Apr 4.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York City, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087986PMC
http://dx.doi.org/10.1002/jso.24228DOI Listing
June 2016

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer.

PLoS One 2015 14;10(8):e0134731. Epub 2015 Aug 14.

Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0134731PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537304PMC
May 2016

Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?

J Clin Oncol 2016 Feb 23;34(5):401-3. Epub 2015 Dec 23.

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.2892DOI Listing
February 2016

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma.

Br J Cancer 2015 Dec 10;113(12):1658-65. Epub 2015 Dec 10.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.416DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702001PMC
December 2015

Morbidity after Total Gastrectomy: Analysis of 238 Patients.

J Am Coll Surg 2015 May 16;220(5):863-871.e2. Epub 2015 Feb 16.

Department of Surgery, Gastric and Mixed Tumor Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2015.01.058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547359PMC
May 2015

Esophageal reinforcement with an extracellular scaffold during total gastrectomy for gastric cancer.

Ann Surg Oncol 2015 Apr 16;22(4):1252-7. Epub 2014 Oct 16.

Department of Surgery, Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-4125-4DOI Listing
April 2015

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions.

Expert Opin Investig Drugs 2014 May 26;23(5):611-28. Epub 2014 Mar 26.

New York University Cancer Institute, NYU Clinical Cancer Center, Division of Hematology/Medical Oncology , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2014.902442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161020PMC
May 2014

Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer.

Am J Clin Oncol 2014 Apr;37(2):126-30

*Department of Medicine, Gastrointestinal Oncology Service †Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/COC.0b013e318271b14fDOI Listing
April 2014

Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.

Ann Surg Oncol 2014 Apr 27;21(4):1130-7. Epub 2013 Dec 27.

Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-3429-0DOI Listing
April 2014

Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.

J Nucl Med 2013 Jun 11;54(6):936-43. Epub 2013 Apr 11.

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.112.110239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967936PMC
June 2013

Distinguishing benign and life-threatening pneumatosis intestinalis in patients with cancer by CT imaging features.

AJR Am J Roentgenol 2013 May;200(5):1042-7

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.12.8942DOI Listing
May 2013

Genomic dysregulation in gastric tumors.

J Surg Oncol 2013 Mar 5;107(3):237-42. Epub 2012 Oct 5.

Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College of Cornell University, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.23263DOI Listing
March 2013

Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.

J Thorac Oncol 2012 Dec;7(12):1815-1822

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31826bb7b2DOI Listing
December 2012

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.

Clin Cancer Res 2011 Oct 10;17(19):6322-8. Epub 2011 Aug 10.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186869PMC
October 2011

MET expression and amplification in patients with localized gastric cancer.

Cancer Epidemiol Biomarkers Prev 2011 May 10;20(5):1021-7. Epub 2011 Mar 10.

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-1
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-10-1080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690490PMC
May 2011

Molecular classification of gastric cancer: a new paradigm.

Clin Cancer Res 2011 May 23;17(9):2693-701. Epub 2011 Mar 23.

Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100216PMC
May 2011

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.

Clin Cancer Res 2011 Apr 19;17(8):2521-7. Epub 2011 Jan 19.

Gastrointestinal and Thoracic Oncology Services, Division of Solid Tumor Oncology, Department of Medicine and Radiology, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2662DOI Listing
April 2011

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations.

J Thorac Oncol 2011 Mar;6(3):569-75

Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318202bffeDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778680PMC
March 2011

A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.

Cancer Chemother Pharmacol 2010 Apr 12;65(5):833-8. Epub 2009 Aug 12.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1088-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711187PMC
April 2010

Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.

Cancer 2010 Feb;116(3):670-5

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.24813
Publisher Site
http://dx.doi.org/10.1002/cncr.24813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815173PMC
February 2010

Do molecular diagnostics add to clinical characteristics in selecting patients for gefitinib treatment?

Nat Clin Pract Oncol 2008 Jan 23;5(1):10-1. Epub 2007 Oct 23.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0997DOI Listing
January 2008